637 - 648 of 7683 results
0.62 CME CREDIT

This patient case follows the course of a young woman who presents with a complaint of recurrent “sinus” headaches. You will review the proper diagnosis of migraine and, through a series of encounters with the patient, learn to individualize management of episodic migraine, including the use of acute pharmacologic treatment options. Please note that any data, indications, and guidelines presented in this activity are current as of the posting on 6/18/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the past few years, there have been major advances in the acute treatment of migraine. Multiple medications and devices have recently received FDA-approval, filling some of the unmet treatment needs for patients with migraine. Join primary care physician Dr. Susan Burke and headache specialist Dr. Stewart Tepper, as they review acute treatment strategies and compare older medications with the newer options, including CGRP antagonists, a serotonin 5-HT1F receptor antagonist, and neuromodulation devices. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 8/31/2020 and they are subject to change as new information is published.


1.5 CME CREDITS

In the last year, two new diseases have emerged with significant and lasting impact on the lung: E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and COVID-19 pneumonia. This session will address new information and challenges related to both diseases. Vaping has increased in popularity, especially among youth, and in late 2019, EVALI was first described. While the outbreak has subsided, recognition of the symptoms, association with marijuana use, and radiographic findings of EVALI remain important. Further, providing tobacco and marijuana cessation guidance remains critical. The COVID-19 pandemic, caused by SARS-Cov2 virus, has burdened healthcare workers and scientists across the globe. COVID-19, often associated with severe pneumonia and systemic illness, has resulted in significant morbidity and mortality in the US and we can continue to learn and discover its full impact. Additionally, COVID-19 has unmasked major health disparities in our healthcare system that we must address.


1.5 CME CREDITS

This session will explore some of the most relevant questions clinicians have as we approach a year into the COVID-19 pandemic. Faculty will review the cardiovascular complications that are directly and indirectly attributed to COVID-19 that have been documented since the onset of the pandemic as sequelae of fear leading to avoidance of prescription medication use, emergency department avoidance, and missed routine healthcare. This session will explore “long” COVID-19 and long-term cardiovascular manifestations and population-level health implications. Faculty will compare COVID-19 to influenza and explore how to distinguish presentation of these viruses. Lastly, we will focus on preventative measures including the development of a COVID-19 vaccine. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/13/2020, and they are subject to change as new information is published.


1 CME CREDIT

New guidelines, evidence, and products present challenges for clinicians who provide gynecologic care. This session focuses on two major clinical areas in gynecology—cervical cancer screening and contraception. We will use a case-based approach to explore current best practices in managing human papillomavirus (HPV) vaccination and Pap testing, as well as to expand evidence-based knowledge of controversies in contraceptive care. Faculty will also provide a brief introduction to the newest contraceptive products available. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/13/2020, and they are subject to change as new information is published.


1 CME CREDIT

Advanced GI dietitian Bethany Doerfler and GI Health Psychologist Sarah Quinton guide you through nutrition and lifestyle trends related to food intolerances, food allergies and GI health in 2020. Critical differences exist between food intolerances and IgE food allergies or Celiac disease. Consumers are often overwhelmed but interested in the role of dietary manipulation on GI health. This talk will focus on data surrounding the accuracy of testing, recommended diet and lifestyle therapy, and the impact of diet on eating behaviors and quality of life. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/14/2020, and they are subject to change as new information is published.


1 CME CREDIT

Anxiety in the Age of COVID-19

1.00 CME/MOC
1.00 AANP | 0.33 Pharmacology

The COVID-19 pandemic has wreaked havoc on the mental health of Americans. Rates of depression, suicide and anxiety have all increased. This session will focus on the negative impact that COVID-19 has had on anxiety. Participants will learn how to support their patients in the context of increased isolation, infection fears and financial insecurity. The appropriate use of medications, including benzodiazepines, will also be reviewed. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/14/2020, and they are subject to change as new information is published.


1 CME CREDIT

Thyroid: "Curbsiders"

1.00 CME/MOC
1.00 AANP | 0.40 Pharmacology


Primary Care Pulse: Live on November 17, 2020

Pri-Med's new weekly CME/CE web series, Primary Care Pulse, features live conversations about timely topics and concerns facing primary care clinicians.


1 CME CREDIT

Confronting Cardio-Oncology: An Emerging Epidemic

1.00 CME/MOC
1.00 AANP | 0.67 Pharmacology

The development of cardio-oncology as a clinical field has been driven by improved therapeutics resulting in a dramatic increase in the number of cancer survivors (~17,000,00 in the United States alone) many of whom suffer cardiovascular complications related to their cancer treatments. Both "traditional" and "targeted" therapies can affect the cardiovascular system resulting in hypertension, heart failure, myocarditis, arrhythmias, vascular disease, and thrombosis. While recurrence of cancer is the eventual cause of death in many "cancer survivors", cardiovascular disease is responsible for substantial morbidity and mortality in this population. Thus, effective means of mitigating cardiovascular complications of cancer therapies would have substantial impact on health. Here we will review novel issues in cardio-oncology and will give a broad overview of this emerging field.


Clinical Considerations in Stroke or Transient Ischemic Attack

Industry Webcast Sponsored by AstraZeneca Pharmaceuticals, LP; Not for CME/CE Credit

• Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA). • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial


0.5 CME CREDIT

Triglycerides and their management have received a great deal of publicity recently due to clinical trial results. Join Dr. Ty Gluckman as he reviews the risks associated with hypertriglyceridemia, discusses available therapeutic options to lower triglycerides, and reconciles the finding of the REDUCE-IT and the STRENGTH trials.